GFAP and congenital isolated hyperinsulinism: To determine the effect of early CHI mouse serum treatment on iNSC-mediated neuroprotection in vivo, we used double-labelling experiments and discovered that GFAP+/Crry+ astrocytes were obvious in the injured cortices of the CHI group on day 14 post-CHI (Fig. 6a).